Pharmaceutically acceptable, as used herein, refers to a material, such as a carrier or diluent, which does not abrogate the biological activity or properties of the compound in reference to the sinonasal cavity or structure, and is relatively or is reduced in toxicity to the sinonasal cavity or structure, i.e., the material is administered to an individual without causing undesirable biological